Report Detail

Request for Sample of this report

Other Global Injectable Drug Delivery Devices Market Report 2018-2029

  • RnM3088498
    • |
  • 22 August, 2023
    • |
  • Global
    • |
  • 141 Pages
    • |
  • HJResearch
    • |
  • Other

Injectable Drug Delivery Devices are medical devices that are used to administer medication into the body through injection. These devices are mainly used for the treatment of immune disorders, cancer, diabetes, and other diseases. Injectable drug delivery devices come in various forms, such as syringes, auto-injectors, pens, and pumps. They are designed to deliver drugs accurately and efficiently, making them a critical component of modern medicine.

The global market for Injectable Drug Delivery Devices is expected to reach US$618 million by 2022, with a compound annual growth rate of 10.25%. One of the key drivers of this growth is the increasing prevalence of chronic diseases such as diabetes and cancer, which require regular injections of medication. The rise in demand for self-administration devices and the development of biologics and biosimilars will also boost the growth of the Injectable Drug Delivery Devices industry.

The major global manufacturers in the Injectable Drug Delivery Devices industry include Dickinson and Company, Baxter International, Schott, Eli Lilly, Pfizer, Gerresheimer, Terumo Corporation, Antares Pharma, Novo Nordisk, Sanofi, Unilife Corporation, Zogenix, Hospira, Presage Bioscience, MicroCHIPS, Pearl Therapeutics, Genentech, and Bend Research. These companies offer a wide range of injectable drug delivery devices, including pre-filled syringes, auto-injectors, pens, pumps, and needle-free injectors.

North America dominates the Injectable Drug Delivery Devices market, followed by Europe and the Asia-Pacific region. The high demand for injectable drug delivery devices in North America is driven by factors such as the presence of a well-established healthcare infrastructure, a large patient population, and a high prevalence of chronic diseases that require regular injections. The Asia-Pacific region presents significant growth opportunities due to the increasing prevalence of chronic diseases, growing disposable income, and rising awareness of injectable drug delivery devices.

The Injectable Drug Delivery Devices industry has several strengths, such as the ability to deliver medication accurately and efficiently, growing demand for self-administration devices, and the development of biologics and biosimilars. However, the industry also faces challenges, such as the high cost of advanced devices, the complexity of drug-device combinations, and intense competition from alternative drug administration methods.

In conclusion, the Injectable Drug Delivery Devices industry is poised for significant growth in the coming years, driven by the increasing prevalence of chronic diseases, the rise in demand for self-administration devices, and the development of biologics and biosimilars. The major global manufacturers are investing in research and development to create innovative products, improve patient outcomes, and expand their market share. North America dominates the market, followed by Europe and the Asia-Pacific region, but there are significant opportunities for growth in emerging markets. The industry should focus on innovation, reducing costs, improving product quality and safety, and developing new products that meet changing customer needs to overcome these challenges and sustain growth in the long term.

The SWOT analysis of the Injectable Drug Delivery Devices industry is as follows:

Strengths:
Injectable drug delivery devices offer accurate and efficient drug administration, improving patient outcomes.
Growing demand for self-administration devices is driving the growth of the Injectable Drug Delivery Devices industry.
The increasing development of biologics and biosimilars is creating opportunities for the industry to develop new devices.
Strong regulatory frameworks around injectable drug delivery devices ensure their safety and efficacy.

Weaknesses:
The high cost of advanced injectable drug delivery devices can limit market adoption rates.
The complexity of drug-device combinations requires significant R&D investment and expertise.
Intense competition from alternative drug administration methods, such as oral medications and transdermal patches.

Opportunities:
Emerging markets, such as the Asia-Pacific region, present significant growth opportunities for the Injectable Drug Delivery Devices industry.
Collaboration with pharmaceutical companies to develop drug-device combination products can create new revenue streams and strengthen market position.
Technological advancements in the field of injectable drug delivery devices, such as needle-free injectors, offer new avenues for innovation and product differentiation.

Threats:
Economic downturns and reduced healthcare budgets can negatively impact the demand for injectable drug delivery devices, hindering the industry's growth prospects.
The emergence of biosimilars and generic drugs can pose a threat to the Injectable Drug Delivery Devices industry's market share.
Intense competition from alternative drug administration methods can cause a decline in demand for injectable drug delivery devices.

Key players in global Injectable Drug Delivery Devices market include:
Dickinson and Company
Baxter International
Schott
Eli Lilly
Pfizer
Gerresheimer
Terumo Corporation
Antares Pharma
Novo Nordik
Sanofi
Unilife Corporation
Zogenix
Hospira
Presage Bioscience
MicroCHIPS
Pearl Therapeutics
Genentech
Bend Research

Market segmentation, by product types:
Devices
Formulation

Market segmentation, by applications:
Immune Disorder
Cancer
Diabetes
Other


1 Industry Overview of Injectable Drug Delivery Devices

  • 1.1 Research Scope
  • 1.2 Market Segmentation by Types of Injectable Drug Delivery Devices
  • 1.3 Market Segmentation by End Users of Injectable Drug Delivery Devices
  • 1.4 Market Dynamics Analysis of Injectable Drug Delivery Devices
    • 1.4.1 Market Drivers
    • 1.4.2 Market Challenges
    • 1.4.3 Market Opportunities
    • 1.4.4 Porter’s Five Forces

2 Major Manufacturers Analysis of Injectable Drug Delivery Devices Industry

  • 2.1 Dickinson and Company
    • 2.1.1 Company Overview
    • 2.1.2 Main Products and Specifications
    • 2.1.3 Injectable Drug Delivery Devices Sales Volume, Revenue, Price and Gross Margin (2018-2023)
    • 2.1.4 Contact Information
  • 2.2 Baxter International
    • 2.2.1 Company Overview
    • 2.2.2 Main Products and Specifications
    • 2.2.3 Injectable Drug Delivery Devices Sales Volume, Revenue, Price and Gross Margin (2018-2023)
    • 2.2.4 Contact Information
  • 2.3 Schott
    • 2.3.1 Company Overview
    • 2.3.2 Main Products and Specifications
    • 2.3.3 Injectable Drug Delivery Devices Sales Volume, Revenue, Price and Gross Margin (2018-2023)
    • 2.3.4 Contact Information
  • 2.4 Eli Lilly
    • 2.4.1 Company Overview
    • 2.4.2 Main Products and Specifications
    • 2.4.3 Injectable Drug Delivery Devices Sales Volume, Revenue, Price and Gross Margin (2018-2023)
    • 2.4.4 Contact Information
  • 2.5 Pfizer
    • 2.5.1 Company Overview
    • 2.5.2 Main Products and Specifications
    • 2.5.3 Injectable Drug Delivery Devices Sales Volume, Revenue, Price and Gross Margin (2018-2023)
    • 2.5.4 Contact Information
  • 2.6 Gerresheimer
    • 2.6.1 Company Overview
    • 2.6.2 Main Products and Specifications
    • 2.6.3 Injectable Drug Delivery Devices Sales Volume, Revenue, Price and Gross Margin (2018-2023)
    • 2.6.4 Contact Information
  • 2.7 Terumo Corporation
    • 2.7.1 Company Overview
    • 2.7.2 Main Products and Specifications
    • 2.7.3 Injectable Drug Delivery Devices Sales Volume, Revenue, Price and Gross Margin (2018-2023)
    • 2.7.4 Contact Information
  • 2.8 Antares Pharma
    • 2.8.1 Company Overview
    • 2.8.2 Main Products and Specifications
    • 2.8.3 Injectable Drug Delivery Devices Sales Volume, Revenue, Price and Gross Margin (2018-2023)
    • 2.8.4 Contact Information
  • 2.9 Novo Nordik
    • 2.9.1 Company Overview
    • 2.9.2 Main Products and Specifications
    • 2.9.3 Injectable Drug Delivery Devices Sales Volume, Revenue, Price and Gross Margin (2018-2023)
    • 2.9.4 Contact Information
  • 2.10 Sanofi
    • 2.10.1 Company Overview
    • 2.10.2 Main Products and Specifications
    • 2.10.3 Injectable Drug Delivery Devices Sales Volume, Revenue, Price and Gross Margin (2018-2023)
    • 2.10.4 Contact Information
  • 2.11 Unilife Corporation
    • 2.11.1 Company Overview
    • 2.11.2 Main Products and Specifications
    • 2.11.3 Injectable Drug Delivery Devices Sales Volume, Revenue, Price and Gross Margin (2018-2023)
    • 2.11.4 Contact Information
  • 2.12 Zogenix
    • 2.12.1 Company Overview
    • 2.12.2 Main Products and Specifications
    • 2.12.3 Injectable Drug Delivery Devices Sales Volume, Revenue, Price and Gross Margin (2018-2023)
    • 2.12.4 Contact Information
  • 2.13 Hospira
    • 2.13.1 Company Overview
    • 2.13.2 Main Products and Specifications
    • 2.13.3 Injectable Drug Delivery Devices Sales Volume, Revenue, Price and Gross Margin (2018-2023)
    • 2.13.4 Contact Information
  • 2.14 Presage Bioscience
    • 2.14.1 Company Overview
    • 2.14.2 Main Products and Specifications
    • 2.14.3 Injectable Drug Delivery Devices Sales Volume, Revenue, Price and Gross Margin (2018-2023)
    • 2.14.4 Contact Information
  • 2.15 MicroCHIPS
    • 2.15.1 Company Overview
    • 2.15.2 Main Products and Specifications
    • 2.15.3 Injectable Drug Delivery Devices Sales Volume, Revenue, Price and Gross Margin (2018-2023)
    • 2.15.4 Contact Information
  • 2.16 Pearl Therapeutics
    • 2.16.1 Company Overview
    • 2.16.2 Main Products and Specifications
    • 2.16.3 Injectable Drug Delivery Devices Sales Volume, Revenue, Price and Gross Margin (2018-2023)
    • 2.16.4 Contact Information
  • 2.17 Genentech
    • 2.17.1 Company Overview
    • 2.17.2 Main Products and Specifications
    • 2.17.3 Injectable Drug Delivery Devices Sales Volume, Revenue, Price and Gross Margin (2018-2023)
    • 2.17.4 Contact Information
  • 2.18 Bend Research
    • 2.18.1 Company Overview
    • 2.18.2 Main Products and Specifications
    • 2.18.3 Injectable Drug Delivery Devices Sales Volume, Revenue, Price and Gross Margin (2018-2023)
    • 2.18.4 Contact Information

3 Global Injectable Drug Delivery Devices Market Analysis by Regions, Manufacturers, Types and End Users

  • 3.1 Global Sales Volume and Revenue of Injectable Drug Delivery Devices by Regions (2018-2023)
  • 3.2 Global Sales Volume and Revenue of Injectable Drug Delivery Devices by Manufacturers (2018-2023)
  • 3.3 Global Sales Volume and Revenue of Injectable Drug Delivery Devices by Types (2018-2023)
  • 3.4 Global Sales Volume and Revenue of Injectable Drug Delivery Devices by End Users (2018-2023)
  • 3.5 Selling Price Analysis of Injectable Drug Delivery Devices by Regions, Manufacturers, Types and End Users in (2018-2023)

4 Northern America Injectable Drug Delivery Devices Market Analysis by Countries, Types and End Users

  • 4.1 Northern America Injectable Drug Delivery Devices Sales Volume and Revenue Analysis by Countries (2018-2023)
  • 4.2 Northern America Injectable Drug Delivery Devices Sales Volume and Revenue Analysis by Types (2018-2023)
  • 4.3 Northern America Injectable Drug Delivery Devices Sales Volume and Revenue Analysis by End Users (2018-2023)
  • 4.4 United States Injectable Drug Delivery Devices Sales Volume, Revenue, Import and Export Analysis (2018-2023)
  • 4.5 Canada Injectable Drug Delivery Devices Sales Volume, Revenue, Import and Export Analysis (2018-2023)

5 Europe Injectable Drug Delivery Devices Market Analysis by Countries, Types and End Users

  • 5.1 Europe Injectable Drug Delivery Devices Sales Volume and Revenue Analysis by Countries (2018-2023)
  • 5.2 Europe Injectable Drug Delivery Devices Sales Volume and Revenue Analysis by Types (2018-2023)
  • 5.3 Europe Injectable Drug Delivery Devices Sales Volume and Revenue Analysis by End Users (2018-2023)
  • 5.4 Germany Injectable Drug Delivery Devices Sales Volume, Revenue, Import and Export Analysis (2018-2023)
  • 5.5 France Injectable Drug Delivery Devices Sales Volume, Revenue, Import and Export Analysis (2018-2023)
  • 5.6 UK Injectable Drug Delivery Devices Sales Volume, Revenue, Import and Export Analysis (2018-2023)
  • 5.7 Italy Injectable Drug Delivery Devices Sales Volume, Revenue, Import and Export Analysis (2018-2023)
  • 5.8 Russia Injectable Drug Delivery Devices Sales Volume, Revenue, Import and Export Analysis (2018-2023)
  • 5.9 Spain Injectable Drug Delivery Devices Sales Volume, Revenue, Import and Export Analysis (2018-2023)
  • 5.10 Netherlands Injectable Drug Delivery Devices Sales Volume, Revenue, Import and Export Analysis (2018-2023)

6 Asia Pacific Injectable Drug Delivery Devices Market Analysis by Countries, Types and End Users

  • 6.1 Asia Pacific Injectable Drug Delivery Devices Sales Volume and Revenue Analysis by Countries (2018-2023)
  • 6.2 Asia Pacific Injectable Drug Delivery Devices Sales Volume and Revenue Analysis by Types (2018-2023)
  • 6.3 Asia Pacific Injectable Drug Delivery Devices Sales Volume and Revenue Analysis by End Users (2018-2023)
  • 6.4 China Injectable Drug Delivery Devices Sales Volume, Revenue, Import and Export Analysis (2018-2023)
  • 6.5 Japan Injectable Drug Delivery Devices Sales Volume, Revenue, Import and Export Analysis (2018-2023)
  • 6.6 Korea Injectable Drug Delivery Devices Sales Volume, Revenue, Import and Export Analysis (2018-2023)
  • 6.7 India Injectable Drug Delivery Devices Sales Volume, Revenue, Import and Export Analysis (2018-2023)
  • 6.8 Australia Injectable Drug Delivery Devices Sales Volume, Revenue, Import and Export Analysis (2018-2023)
  • 6.9 Indonesia Injectable Drug Delivery Devices Sales Volume, Revenue, Import and Export Analysis (2018-2023)
  • 6.10 Vietnam Injectable Drug Delivery Devices Sales Volume, Revenue, Import and Export Analysis (2018-2023)

7 Latin America Injectable Drug Delivery Devices Market Analysis by Countries, Types and End Users

  • 7.1 Latin America Injectable Drug Delivery Devices Sales Volume and Revenue Analysis by Countries (2018-2023)
  • 7.2 Latin America Injectable Drug Delivery Devices Sales Volume and Revenue Analysis by Types (2018-2023)
  • 7.3 Latin America Injectable Drug Delivery Devices Sales Volume and Revenue Analysis by End Users (2018-2023)
  • 7.4 Brazil Injectable Drug Delivery Devices Sales Volume, Revenue, Import and Export Analysis (2018-2023)
  • 7.5 Mexico Injectable Drug Delivery Devices Sales Volume, Revenue, Import and Export Analysis (2018-2023)
  • 7.6 Argentina Injectable Drug Delivery Devices Sales Volume, Revenue, Import and Export Analysis (2018-2023)
  • 7.7 Colombia Injectable Drug Delivery Devices Sales Volume, Revenue, Import and Export Analysis (2018-2023)

8 Middle East & Africa Injectable Drug Delivery Devices Market Analysis by Countries, Types and End Users

  • 8.1 Middle East & Africa Injectable Drug Delivery Devices Sales Volume and Revenue Analysis by Countries (2018-2023)
  • 8.2 Middle East & Africa Injectable Drug Delivery Devices Sales Volume and Revenue Analysis by Types (2018-2023)
  • 8.3 Middle East & Africa Injectable Drug Delivery Devices Sales Volume and Revenue Analysis by End Users (2018-2023)
  • 8.4 Turkey Injectable Drug Delivery Devices Sales Volume, Revenue, Import and Export Analysis (2018-2023)
  • 8.5 Saudi Arabia Injectable Drug Delivery Devices Sales Volume, Revenue, Import and Export Analysis (2018-2023)
  • 8.6 South Africa Injectable Drug Delivery Devices Sales Volume, Revenue, Import and Export Analysis (2018-2023)
  • 8.7 Egypt Injectable Drug Delivery Devices Sales Volume, Revenue, Import and Export Analysis (2018-2023)

9 Marketing Channel, Distributors and Traders Analysis

  • 9.1 Marketing Channel
    • 9.1.1 Direct Channel
    • 9.1.2 Indirect Channel
  • 9.2 Distributors and Traders

10 Global Injectable Drug Delivery Devices Market Forecast by Regions, Countries, Manufacturers, Types and End Users

  • 10.1 Global Sales Volume and Revenue Forecast of Injectable Drug Delivery Devices by Regions (2024-2029)
  • 10.2 Global Sales Volume and Revenue Forecast of Injectable Drug Delivery Devices by Types (2024-2029)
  • 10.3 Global Sales Volume and Revenue Forecast of Injectable Drug Delivery Devices by End Users (2024-2029)
  • 10.4 Global Revenue Forecast of Injectable Drug Delivery Devices by Countries (2024-2029)
    • 10.4.1 United States Revenue Forecast (2024-2029)
    • 10.4.2 Canada Revenue Forecast (2024-2029)
    • 10.4.3 Germany Revenue Forecast (2024-2029)
    • 10.4.4 France Revenue Forecast (2024-2029)
    • 10.4.5 UK Revenue Forecast (2024-2029)
    • 10.4.6 Italy Revenue Forecast (2024-2029)
    • 10.4.7 Russia Revenue Forecast (2024-2029)
    • 10.4.8 Spain Revenue Forecast (2024-2029)
    • 10.4.9 Netherlands Revenue Forecast (2024-2029)
    • 10.4.10 China Revenue Forecast (2024-2029)
    • 10.4.11 Japan Revenue Forecast (2024-2029)
    • 10.4.12 Korea Revenue Forecast (2024-2029)
    • 10.4.13 India Revenue Forecast (2024-2029)
    • 10.4.14 Australia Revenue Forecast (2024-2029)
    • 10.4.15 Indonesia Revenue Forecast (2024-2029)
    • 10.4.16 Vietnam Revenue Forecast (2024-2029)
    • 10.4.17 Brazil Revenue Forecast (2024-2029)
    • 10.4.18 Mexico Revenue Forecast (2024-2029)
    • 10.4.19 Argentina Revenue Forecast (2024-2029)
    • 10.4.20 Colombia Revenue Forecast (2024-2029)
    • 10.4.21 Turkey Revenue Forecast (2024-2029)
    • 10.4.22 Saudi Arabia Revenue Forecast (2024-2029)
    • 10.4.23 South Africa Revenue Forecast (2024-2029)
    • 10.4.24 Egypt Revenue Forecast (2024-2029)

11 Industry Chain Analysis of Injectable Drug Delivery Devices

  • 11.1 Upstream Major Raw Materials and Equipment Suppliers Analysis of Injectable Drug Delivery Devices
    • 11.1.1 Major Raw Materials Suppliers with Contact Information Analysis of Injectable Drug Delivery Devices
    • 11.1.2 Major Equipment Suppliers with Contact Information Analysis of Injectable Drug Delivery Devices
  • 11.2 Downstream Major Consumers Analysis of Injectable Drug Delivery Devices
  • 11.3 Major Suppliers of Injectable Drug Delivery Devices with Contact Information
  • 11.4 Supply Chain Relationship Analysis of Injectable Drug Delivery Devices

12 Injectable Drug Delivery Devices New Project Investment Feasibility Analysis

  • 12.1 Injectable Drug Delivery Devices New Project SWOT Analysis
  • 12.2 Injectable Drug Delivery Devices New Project Investment Feasibility Analysis
    • 12.2.1 Project Name
    • 12.2.2 Investment Budget
    • 12.2.3 Project Product Solutions
    • 12.2.4 Project Schedule

13 Injectable Drug Delivery Devices Research Findings and Conclusion

    14 Appendix

    • 14.1 Research Methodology
    • 14.2 References and Data Sources
      • 14.2.1 Primary Sources
      • 14.2.2 Secondary Paid Sources
      • 14.2.3 Secondary Public Sources
    • 14.3 Abbreviations and Units of Measurement
    • 14.4 Author Details

    Summary:
    Get latest Market Research Reports on Injectable Drug Delivery Devices. Industry analysis & Market Report on Injectable Drug Delivery Devices is a syndicated market report, published as Global Injectable Drug Delivery Devices Market Report 2018-2029. It is complete Research Study and Industry Analysis of Injectable Drug Delivery Devices market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,200.00
    		$5,800.00
    		2,467.20
    		4,471.80
    		2,963.20
    		5,370.80
    		490,368.00
    		888,792.00
    		269,856.00
    		489,114.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo